ArticleJournal of hepatocellular carcinoma2026
Erratum: Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.